Macrolide Antibiotics Market Demands, Key Players, Insights, Research and Forecast 2030 | MRFR
Macrolide
Antibiotics Market Highlights
Macrolides such as
azithromycin, clarithromycin, and erythromycin are a class of antibiotics that
inhibit protein synthesis. It acts as a bacteriostatic agent against many
strains of corynebacterial, listeria, moxicella, streptococci, Neisseria
meningitides, Staphylococci, Clostridia, and Haemophilus sp. It is used
for the treatment of bacterial infections, such as nose, ear, and throat infections,
chest infections, skin infections as well as mouth and dental infections. They
are also used as an alternative to penicillin.
The global macrolide
antibiotics market is expected to show a sharp growth over the forecast period owing to an
increasing demand for macrolide across the globe. Rising prevalence of
bacterial skin infections and rising number of dermatology clinics also favour
the market growth. According to a study published in the Journal of the
American College of Cardiology, macrolide antibiotics may increase the risk of
sudden cardiac death, ventricular tachyarrhythmias, and cardiovascular death in
patients, which may hinder the growth of the market over the assessment period.
The Macrolide
Antibiotics Market is anticipated to reach USD 146,432.1 Million by 2030 at
13.1% CAGR during the forecast period 2022-2030.
Regional Analysis
The global
macrolide antibiotics market consists of
four regions: the Americas, Europe, Asia Pacific, and the Middle East &
Africa.
The Americas
dominates the global macrolide antibiotics market. It comprises of two regions
namely North America and South America. The market in the American region is
driven by the rising prescription of antibiotics in out-patient department in
the U.S.
In Europe,
increasing use of azithromycin, and erythromycin has lead to the rise in
the demand for the macrolide antibiotics. France accounts for the largest
market share followed by Germany owing to the increasing incidence of skin
diseases.
Asia Pacific is the
fastest growing and potential market for the macrolide antibiotics whose growth
is attributed to the increasing awareness about the use of macrolides for the
treatment various rare skin diseases and its side effects. Expansion of
healthcare system in developing countries in Asia Pacific also favours the
market growth.
The Middle East
& Africa is expected to witness a steady growth in this market.
Major Players in Macrolide
antibiotics Market
The global
macrolide antibiotics market players are Merck Sharp & Dohme Corp
(U.S.), Pfizer Inc. (U.S.), Neo Química (Brazil), Macrolide Pharmaceuticals
(U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Fresenius
Kabi USA (U.S.), Sandoz International GmbH (Germany), Gland Pharma Limited
(India), Mylan N.V. (U.S.), and WOCKHARDT (U.S.)
Segmentation
The global macrolide
antibiotics market report is segmented based on drugs, which includes azithromycin,
clarithromycin, erythromycin, fidaxomicin, and telithromycin.
Based on route of
administration, the market is segmented into oral, parenteral. Based on
indication, the market is segmented into infection due to mycoplasma
pneumoniae, legionella sp, or Bordetella pertussis, symptomatic
cat-scratch disease, bacillary angiomatosis, peliosis hepatis in patients with
AIDS, cerebral toxoplasmosis, uncomplicated skin infections, and others. On the
basis of end user, the market is segmented into hospitals, dermabrasion, dermatology
clinics, pharmaceutical companies, and others.
About Market
Research Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New York
10013
United States of
America
+1 628 258 0071
Email:
sales@marketresearchfuture.com
Comments
Post a Comment